Immobility, pain and depression less likely for male survivors, research suggests
Endocrine Society echoes recent FDA concerns about the popular supplements
Cardiologist offers advice to lower your risk of heart disease
In company-funded trial, device outperformed usual tests in detecting atrial fibrillation
Researchers can't say for sure, but brain bleeds were more common among those with low levels of the vitamin
Made no difference in long-term outcomes, but other drugs being developed might, study says
Doctors should assess overall risks in premenopausal women, study suggests
Less than 6 percent of those getting back behind the wheel got formal review of road readiness
Study found brisk walking, tennis lowered chances of brain attack by 20 percent
Tears in vessels may be partially to blame, but the exact link is unclear, researchers say
However, most live within an hour of hospital that can give proper treatment, study finds
Even the elderly and those who had more severe attacks showed less disability later
Researchers find those with brain stem injury are more likely to develop the condition
Almost two-thirds of those enrolled in health plans have been properly treated, but more must be done
Further investigation needed to understand this racial disparity, researchers say
Study suggests stroke hospitalizations and death rates tied to changes in temperature and humidity
Within 24 hours of use, risk increases almost sevenfold, researchers report
The brain attacks are rare in children, experts note, and study found vaccines may offer some protection
Some studies had suggested naproxen (Aleve) might pose less of a threat than other painkillers
Marketed as Onglyza and Kombiglyze XR, drug appears to have no effect on heart attack or stroke risk
Study found those getting medication/therapy were half as likely to develop cardiovascular trouble
Studies suggest naproxen (Aleve) may pose less of a threat
Pregnancy, childbirth, female hormones can all influence lifelong risk, experts say
Study found no effect, but longer-term trials may be needed to see a benefit, experts add
It will include now-deceased North Carolina woman whose appearance in first initiative stunned many viewers
It told them what the symptoms are and what to do if they see someone having one
American Lung Association points to legislative inaction by states, stronger push by Big Tobacco
And obese middle-aged people die an average of more than 7 years sooner, U.S. statistics show
Packaging problem could allow air, moisture to affect drug's effectiveness, company says
Study also found increased odds of heart attack, mini-stroke in older adults years after infection
Researchers looked at nearly 70,000 adults in southeastern U.S.
People with pre-diabetes appear to benefit from adding extra steps to their daily stroll
International study looked at fiber from wide range of sources
But direct link not proven
But the risk is temporary as blood thinner use starts, and could be overcome by other means, experts say
But patients should not keep smoking while on nicotine-replacement therapy, experts warn
Experts unsure exactly why, but better prevention and after-stroke care may be factors
Researchers weigh results of 8 studies, find excess pounds raise death risk over time
Preliminary study finds benefits long after attack
Clots are arising at increasing rate for people using the HeartMate II device, although reasons are unclear
Although not yet on the market, magnetic technology may let users move with greater speed, ease
One day's dose of Alka-Seltzer exceeds recommended total intake of salt
Lower your blood pressure, cholesterol and blood sugar levels, analysis concludes
Small trial found the drug reduced blood clotting more when taken at night than in the morning
They say too many people would get the cholesterol-lowering drugs; heart groups defend the recommendations
Damage to blood vessels of the retinas and kidneys tied to higher risk for atrial fibrillation, study found
Experimental brain-computer technology still a long way off, doctors say
New study finds reminder texts help patients stay on the right track for health
Atrial fibrillation is a potentially fatal condition affecting more and more people
British study suggests the number of weekly hours walked, not how fast, is what matters